Skip to Content
You are currently on the new version of our website. Access the old version .

16 Results Found

  • Article
  • Open Access
5 Citations
3,068 Views
17 Pages

The Efficacy of an N-Acetylcysteine–Antibiotic Combination Therapy on Achromobacter xylosoxidans in a Cystic Fibrosis Sputum/Lung Cell Model

  • Aditi Aiyer,
  • Theerthankar Das,
  • Gregory S. Whiteley,
  • Trevor Glasbey and ,
  • Frederik H. Kriel,
  • Jessica Farrell and
  • Jim Manos
  • + 2 authors+ 0 author

10 November 2022

Cystic fibrosis (CF) is a disorder causing dysfunctional ion transport resulting in the accumulation of viscous mucus. This environment fosters a chronic bacterial biofilm-associated infection in the airways. Achromobacter xylosoxidans, a gram-negati...

(This article belongs to the Section Biomedical Engineering and Materials)
  • Article
  • Open Access
173 Citations
12,425 Views
11 Pages

Soluble Fibre Meal Challenge Reduces Airway Inflammation and Expression of GPR43 and GPR41 in Asthma

  • Isabel Halnes,
  • Katherine J. Baines,
  • Bronwyn S. Berthon,
  • Lesley K. MacDonald-Wicks and ,
  • Peter G. Gibson and
  • Lisa G. Wood
  • + 1 author+ 0 author

10 January 2017

Short chain fatty acids (SCFAs) are produced following the fermentation of soluble fibre by gut bacteria. In animal models, both dietary fibre and SCFAs have demonstrated anti-inflammatory effects via the activation of free fatty acid receptors, such...

(This article belongs to the Special Issue Dietary Fibers and Human Health)
  • Article
  • Open Access
1,052 Views
18 Pages

Sputum Glutaredoxin 1 and Protein S-Glutathionylation in COPD

  • Ine Kuipers,
  • Renske Krijgsman,
  • Renaud Louis,
  • Jean-Louis Corhay and ,
  • Thibault Azevedo Mendes,
  • Guy G. Brusselle,
  • Ken R. Bracke and
  • Niki L. Reynaert
  • + 3 authors+ 0 author

Alterations in glutathione and its metabolism contribute to oxidative stress in COPD, but the role of S-glutathionylation (PSSG) and its major regulator glutaredoxin 1 (Grx1) remains unclear. This study investigated the Grx1/PSSG axis in sputum of CO...

(This article belongs to the Special Issue Oxidative Stress and Airway Diseases)
  • Article
  • Open Access
14 Citations
6,256 Views
13 Pages

Magnetofection Enhances Lentiviral-Mediated Transduction of Airway Epithelial Cells through Extracellular and Cellular Barriers

  • Stefano Castellani,
  • Clara Orlando,
  • Annalucia Carbone,
  • Sante Di Gioia and
  • Massimo Conese

23 November 2016

Gene transfer to airway epithelial cells is hampered by extracellular (mainly mucus) and cellular (tight junctions) barriers. Magnetofection has been used to increase retention time of lentiviral vectors (LV) on the cellular surface. In this study, m...

(This article belongs to the Special Issue Gene Therapy)
  • Article
  • Open Access
3 Citations
1,446 Views
27 Pages

Nrp1 Signaling Reprograms Glutathione Metabolism to Drive Mitochondrial Dysfunction in Severe Asthma

  • Junwen Huang,
  • Wenqu Zhao,
  • Ying Chen,
  • Yaoxin Chen and ,
  • Zhaoqian Gong,
  • Yanyan Ma,
  • Yuemao Li,
  • Dapeng Hu,
  • Shuyu Huang and
  • Haijin Zhao
  • + 10 authors+ 5 authors

Mitochondrial dysfunction drives persistent inflammation in severe asthma, yet its upstream metabolic regulation remains unclear. Induced sputum from patients with severe asthma was analyzed and integrated with transcriptomic datasets from independen...

(This article belongs to the Section Health Outcomes of Antioxidants and Oxidative Stress)
  • Review
  • Open Access
40 Citations
10,379 Views
20 Pages

Extracellular Vesicles from Airway Secretions: New Insights in Lung Diseases

  • Laura Pastor,
  • Elisabeth Vera,
  • Jose M. Marin and
  • David Sanz-Rubio

Lung diseases (LD) are one of the most common causes of death worldwide. Although it is known that chronic airway inflammation and excessive tissue repair are processes associated with LD such as asthma, chronic obstructive pulmonary disease (COPD) o...

(This article belongs to the Special Issue Exosomes)
  • Feature Paper
  • Article
  • Open Access
1 Citations
3,145 Views
15 Pages

Type-2 Inflammation in Health and Disease: Prevalence, Risk Factors and Multimorbidity

  • Charmaine J. M. Lim,
  • Christoph Gross,
  • Marie-Kathrin Breyer,
  • Robab Breyer-Kohansal and ,
  • Emiel F. M. Wouters and
  • Sylvia Hartl
  • + 1 author+ 0 author

6 November 2024

Background: In patients with airflow obstruction, the levels of biomarkers of Type-2 (T2) inflammation serve to predict the effectiveness of inhaled corticosteroid and biological therapies. Elevated biomarkers of T2 inflammation, including fractional...

(This article belongs to the Special Issue Clinical Advances in Chronic Obstructive Pulmonary Disease and Its Complications: Part II)
  • Review
  • Open Access
10 Citations
9,814 Views
24 Pages

13 January 2024

The implementation of cystic fibrosis (CF) transmembrane conductance regulator (CFTR) modulator drugs into clinical practice has been attaining remarkable therapeutic outcomes for CF, a life-threatening autosomal recessive genetic disease. However, t...

(This article belongs to the Section Pharmacogenetics)
  • Article
  • Open Access
10 Citations
3,815 Views
14 Pages

The Anti-Microbial Peptide (Lin-SB056-1)2-K Reduces Pro-Inflammatory Cytokine Release through Interaction with Pseudomonas aeruginosa Lipopolysaccharide

  • Lucia Grassi,
  • Arianna Pompilio,
  • Esingül Kaya,
  • Andrea C. Rinaldi and ,
  • Enrico Sanjust,
  • Giuseppantonio Maisetta,
  • Aurélie Crabbé,
  • Giovanni Di Bonaventura,
  • Giovanna Batoni and
  • Semih Esin
  • + 5 authors+ 0 author

The ability of many anti-microbial peptides (AMPs) to modulate the host immune response has highlighted their possible therapeutic use to reduce uncontrolled inflammation during chronic infections. In the present study, we examined the anti-inflammat...

(This article belongs to the Special Issue Therapeutic Use of Antimicrobial Peptides: Joys and Sorrows)
  • Article
  • Open Access
14 Citations
4,284 Views
20 Pages

Diversification of Pseudomonas aeruginosa Biofilm Populations under Repeated Phage Exposures Decreases the Efficacy of the Treatment

  • Mark Grevsen Martinet,
  • Mara Lohde,
  • Doaa Higazy,
  • Christian Brandt and ,
  • Mathias W. Pletz,
  • Mathias Middelboe,
  • Oliwia Makarewicz and
  • Oana Ciofu
  • + 3 authors+ 0 author

Phage therapy has been proposed as a therapeutic alternative to antibiotics for the treatment of chronic, biofilm-related P. aeruginosa infections. To gain a deeper insight into the complex biofilm–phage interactions, we investigated in the pre...

(This article belongs to the Special Issue Biotechnological Applications of Bacteriophages and Enteric Viruses)
  • Article
  • Open Access
4 Citations
10,411 Views
26 Pages

Revealing the Hidden Impacts: Insights into Biological Aging and Long-Term Effects in Pauci- and Asymptomatic COVID-19 Healthcare Workers

  • Manuela Campisi,
  • Luana Cannella,
  • Anna Bordin,
  • Angelo Moretto and ,
  • Maria Luisa Scapellato,
  • Paola Mason,
  • Filippo Liviero,
  • Sofia Pavanello and
  • on behalf of Occupational Medicine Working Group
  • + 4 authors+ 0 author

This study explores the role of inflammation and oxidative stress, hallmarks of COVID-19, in accelerating cellular biological aging. We investigated early molecular markers—DNA methylation age (DNAmAge) and telomere length (TL)—in blood l...

(This article belongs to the Special Issue Long-COVID and Its Complications)
  • Article
  • Open Access
2 Citations
4,207 Views
13 Pages

Distinguishing SARS-CoV-2 Infection and Non-SARS-CoV-2 Viral Infections in Adult Patients through Clinical Score Tools

  • Rujipas Sirijatuphat,
  • Kulprasut Sirianan,
  • Navin Horthongkham,
  • Chulaluk Komoltri and
  • Nasikarn Angkasekwinai

This study aimed to determine distinguishing predictors and develop a clinical score to differentiate COVID-19 and common viral infections (influenza, respiratory syncytial virus (RSV), dengue, chikungunya (CKV), and zika (ZKV)). This retrospective s...

(This article belongs to the Special Issue COVID-19 Variants, Vaccines and New Waves)
  • Review
  • Open Access
17 Citations
4,274 Views
27 Pages

Redefining the Diagnostic and Therapeutic Landscape of Non-Small Cell Lung Cancer in the Era of Precision Medicine

  • Shumayila Khan,
  • Saurabh Upadhyay,
  • Sana Kauser,
  • Gulam Mustafa Hasan and ,
  • Wenying Lu,
  • Maddison Waters,
  • Md Imtaiyaz Hassan and
  • Sukhwinder Singh Sohal
  • + 3 authors+ 0 author

12 November 2025

Non-small cell lung cancer (NSCLC) remains a leading cause of cancer-related mortality globally, driven by marked molecular and cellular heterogeneity that complicates diagnosis and treatment. Despite advances in targeted therapies and immunotherapie...

(This article belongs to the Section Oncology)
  • Article
  • Open Access
9 Citations
3,652 Views
11 Pages

Elastase-Activated Antimicrobial Peptide for a Safer Pulmonary Treatment of Cystic Fibrosis Infections

  • Margherita Degasperi,
  • Riccardo Sgarra,
  • Mario Mardirossian,
  • Sabrina Pacor and ,
  • Massimo Maschio and
  • Marco Scocchi
  • + 1 author+ 0 author

28 February 2022

As bioactive small proteins with antimicrobial and immunomodulatory activities that are naturally produced by all living organisms, antimicrobial peptides (AMPs) have a marked potential as next-generation antibiotics. However, their development as an...

(This article belongs to the Special Issue 10th Anniversary of Antibiotics—Feature Papers)
  • Article
  • Open Access
2 Citations
1,956 Views
14 Pages

Efficacy of EA575 as an Antitussive and Mucoactive Agent in Preclinical In Vivo Models

  • Matthias Hufnagel,
  • André Rademaekers,
  • Anika Weisert,
  • Hanns Häberlein and
  • Sebastian Franken

Background: The efficacy of EA575 in the treatment of respiratory diseases is described in various clinical studies, improving patients’ disease-related symptoms. However, mechanistic in vivo data proving its beneficial effects are limited. Met...

(This article belongs to the Section Drug Discovery, Development and Delivery)
  • Article
  • Open Access
1 Citations
4,232 Views
12 Pages

Effects of Cheonwangbosim-dan in a Mouse Model of Chronic Obstructive Pulmonary Disease: Anti-Inflammatory and Anti-Fibrotic Therapy

  • Jee Hyun Kang,
  • Eunhye Jung,
  • Eun-Ju Hong,
  • Eun Bok Baek and ,
  • Mee-Young Lee and
  • Hyo-Jung Kwun
  • + 1 author+ 0 author

31 January 2023

Chronic obstructive pulmonary disease (COPD) is a lung illness, marked by dyspnea, coughing, and sputum production. Cheonwangbosim-dan (CBD) is a traditional East Asian medicine, consisting of a combination of 15 medicinal herbs, which is frequently...

(This article belongs to the Special Issue Bioactive Compounds from Natural Products - Volume II)